Validation of Two Wrist-worn Devices for the Assessment of Energy Expenditure in Cardiac Patients.

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

June 27, 2018

Study Completion Date

June 27, 2018

Conditions
Coronary Artery DiseaseHeart Failure With Reduced Ejection Fraction
Interventions
DEVICE

Fitbit Charge 2

Energy expenditure (kcal) assessed by this activity tracker will be compared with indirect calorimetry (Oxycon Mobile) during a laboratory activity protocol. Two groups will be assessed: patients with stable coronary artery disease (CAD) and patients with heart failure with reduced ejection fraction (HFrEF).

DEVICE

Mio Slice

Energy expenditure (kcal) assessed by this activity tracker will be compared with indirect calorimetry (Oxycon Mobile) during a laboratory activity protocol. Two groups will be assessed: patients with stable coronary artery disease (CAD) and patients with heart failure with reduced ejection fraction (HFrEF).

DEVICE

Oxycon Mobile

"The Oxycon Mobile will be used as the reference method/golden standard to calculate energy expenditure (kcal). This device (consisting of a face mask and gas analyzer unit) will be worn during the entire laboratory activity protocol.~Two groups will be assessed: patients with stable coronary artery disease (CAD) and patients with heart failure with reduced ejection fraction (HFrEF)."

Trial Locations (1)

5504 DB

Máxima Medical Centre, Veldhoven

Sponsors
All Listed Sponsors
lead

Maxima Medical Center

OTHER